When validating automated systems from third-party providers, using the V model and failure modes effects and criticality analysis (FMECA) early in the process can help.
David Beale
Advertisement
David Beale is Technical Director at GB Innomech Ltd (UK).
Articles by David Beale
Advertisement
Latest Updated Articles
The benefits of risk-based analyses during system validationPublished: September 1st 2009 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
CPHI 2025 Awards Spotlight Breakthroughs in Pharmaceutical Manufacturing and API Development
2
AI and Human Collaboration Essential for Bio/pharma Innovation
3
Sustainability and Stability in Excipients
4
Centralizing AI Strategy, Ensuring Process Integrity, and Balancing Quick Wins with Long-Term Drug Design in Bio/pharma
5
